FDA Approved: SILODOSIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for silodosin under the ANDA206541, enabling the generic product's continued marketing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Silodosin (Silodosin)

Snippet

SUPPL AP for SILODOSIN (SILODOSIN)